Advertisement Lupin enters into clinical research partnership with Acceliant - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Lupin enters into clinical research partnership with Acceliant

India-based drugmaker Lupin has entered into partnership with Acceliant, a provider of advanced clinical trial data management solutions, to use its clinical trial platform for drug research programs.

Acceliant platforms offer smooth execution of clinical data management activities such as database design, UAT and several report formats for business intelligence.

These platforms give Lupin a collaborative environment that brings global research teams to work within a single shared environment.

Acceliant CTO Ven Thangaraj said: "This is an excellent platform for us to showcase our eClinical suite of products that deliver end-to-end clinical trial data management solutions."

Since 1999, Acceliant has been offering solutions in the clinical trial management space and it caters to the needs of the pharmaceutical, biotechnology, medical device, CRO and non-profit drug research industries.

Lupin vice-president Ravishekar Kasibhatta said: "Acceliant proved to be our partner of choice given its excellent track record and competency in clinical trial solutions, and are a part of multiple measures that we are taking to ensure ‘Quality-by-design’ and ensure clinical trial excellence.

"Acceliant’s eClinical suite will go a long way in helping us to cost-effectively streamline and expedite our clinical trial processes."